Ticker ACOR – Acorda – sales, description, marketcap – Tickerday.com

ACOR

Acorda

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 25.52M; Volume: 1.43M; AvgVol 3m: 3.77M; Beta: 1.42;

Cost estimate:

P/E: –; EPS: -4.67; EPS growth quarter/prev quarter: 36.90%;

EPS growth this year: 4.70%; EPS growth past 5 years: 16.45%;

EPS ttm: -4.67;

P/S: 0.18; P/B: 0.11; P/Cashflow: 0.43; P/FCF: ;

Sales: 159.94M; Sales growth quarter/prev quarter: -32.90%; Sales growth past 5 years: -13.70%;

Profitability:

Gross Margin: 83.00%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -28.10%; ROE – return on equity: -74.60%; LT Debt/Equity: 0.54; Total Debt/Equity: 0.77;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.50%; Insider Transactions:0.00%;

Institutional Ownership: 61.00%; Institutional Transactions: -41.19%;

Data update: 07.10.2020.